Globally, 262 million patients are diagnosed with asthma as of 2019, while in India, the asthma rate is at 2,241 per 100,000. These figures, according to the World Population Review, are significantly ...
RANCHO CUCAMONGA, CA / ACCESS Newswire / April 6, 2026 / Amphastar Pharmaceuticals, Inc. (NASDAQ:AMPH) ("Amphastar" or the "Company") announced today that Bill Peters, CFO, Tony Marrs, EVP of ...
Amphastar is a biopharmaceutical company that focuses on developing, manufacturing, and commercializing technically challenging generic and proprietary injectable, inhalation, and intranasal products.
RANCHO CUCAMONGA, CA / ACCESS Newswire / April 6, 2026 / Amphastar Pharmaceuticals, Inc. (NASDAQ:AMPH) ("Amphastar" or the "Company") announced today that Bill Peters, CFO, Tony Marrs, EVP of ...
The Food and Drug Administration is pulling Primatene Mist from the market Jan. 1. The ban is the result of the Montreal Protocol treaty, which prohibits the sale of certain products containing ...
Amphastar Pharmaceuticals, Inc. engages in developing, manufacturing, marketing, and selling technically challenging generic and proprietary injectable, inhalation, and intranasal products, and ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results